Erythrovirus B19 (B19V) in patients with acute febrile illness suspected of arboviruses in Mato Grosso do Sul, Brazil
Authors:
- Gislene Garcia C. LichsGLGislene Garcia C. Lichs
- Zoraida del Carmen Fernandez GrilloZGZoraida del Carmen Fernandez Grillo
- Valdinete Alves Do NascimentoVNValdinete Alves Do Nascimento
- Daniel Maximo Corrêa AlcantaraDADaniel Maximo Corrêa Alcantara
- Everton Ferreira LemosELEverton Ferreira Lemos
- Cristiano M. Espínola CarvalhoCristiano M. Espínola Carvalho
- Luiz Henrique Ferraz DemarchiLuiz Henrique Ferraz Demarchi
- Crhistinne Carvalho Maymone GonçalvesCGCrhistinne Carvalho Maymone Gonçalves
- Felipe Gomes NavecaFelipe Gomes Naveca
- Alexsandra Rodrigues de Mendonça FavachoAFAlexsandra Rodrigues de Mendonça Favacho
Preprint
Abstract
Human Erythrovirus (parvovirus) B19 infection can produce symptoms similar to those produced by Dengue, Chikungunya, and Zika viruses, making clinical diagnosis difficult. The importance of erythrovirus B19 in human pathology has been increased and reported in numerous studies published globally. The B19V infection was investigated by real-time PCR in samples from patients with signs and symptoms related to classic arboviral symptoms. This study was conducted to provide information on the genetic diversity of Human Erythrovirus B19 (B19V) circulating in the state of Mato Grosso do Sul, Midwest region of Brazil, from 2017 to 2022. A total of 773 sera samples of patients with negative diagnostic results for Dengue, Chikungunya, and Zika, during the study period were analyzed. Erythrovirus DNA was found in 10.6% (82/773) of patients, among them 10 were pregnant women. Four samples were completely sequenced, and the other five partially, to genotype by phylogenetic reconstruction. All samples belong to worldwide dispersed genotype 1, subgenotype 1a. These results demonstrate the importance of including B19V in differential laboratory diagnosis for epidemiological purposes and appropriate patient management. The diagnosis for B19V should be performed, particularly among pregnant women, immunocompromised patients, and individuals with hemolytic diseases, as the infection is more severe in these cases.Keywords
This publication has 35 references indexed in Scilit:
- Molecular and phylogenetic analyses of human Parvovirus B19 isolated from Brazilian patients with sickle cell disease and β‐thalassemia major and healthy blood donorsJournal of Medical Virology, 2012
- Global Co-Existence of Two Evolutionary Lineages of Parvovirus B19 1a, Different in Genome-Wide Synonymous PositionsPLOS ONE, 2012
- Molecular characterization of human erythrovirus B19 strains obtained from patients with several clinical presentations in the Amazon region of BrazilJournal of Clinical Virology, 2008
- Identification and genetic diversity of two human parvovirus B19 genotype 3 subtypesJournal of General Virology, 2007
- Phylogenetic analysis of human parvovirus B19, indicating two subgroups of genotype 1 in Vietnamese patientsJournal of General Virology, 2006
- Laboratory assessment and diagnosis of congenital viral infections: Rubella, cytomegalovirus (CMV), varicella-zoster virus (VZV), herpes simplex virus (HSV), parvovirus B19 and human immunodeficiency virus (HIV)Reproductive Toxicology, 2006
- Sequence Variability of Human Erythroviruses Present in Bone Marrow of Brazilian Patients with Various Parvovirus B19-Related Hematological SymptomsJournal of Clinical Microbiology, 2006
- Human parvovirus B19 infections among exanthematic diseases notified as measlesRevista da Sociedade Brasileira de Medicina Tropical, 1997
- Parvovirus B19 antibodies in sera of patients with unexplained exanthemata from Belém, Pará, BrazilMemórias do Instituto Oswaldo Cruz, 1993
- Statistical analysis of animal orientation dataAnimal Behaviour, 1992